Journal
Journal of the American Academy of Dermatology
Publication Date
6-1-2020
Volume
82
Issue
6
First Page
1328
Last Page
1336
Document Type
Open Access Publication
DOI
10.1016/j.jaad.2020.02.060
Rights and Permissions
Silverberg JI, Yosipovitch G, Simpson EL, Kim BS, Wu JJ, Eckert L, Guillemin I, Chen Z, Ardeleanu M, Bansal A, Kaur M, Rossi AB, Graham NMH, Patel N, Gadkari A. Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS. J Am Acad Dermatol. 2020 Jun;82(6):1328-1336. doi: 10.1016/j.jaad.2020.02.060. Copyright 2020 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Silverberg, Jonathan I.; Yosipovitch, Gil; Simpson, Eric L.; Kim, Brian S.; Wu, Jashin J.; Eckert, Laurent; Guillemin, Isabelle; Chen, Zhen; Ardeleanu, Marius; Bansal, Ashish; Kaur, Mandeep; Rossi, Ana B.; Graham, Neil M. H.; Patel, Naimish; and Gadkari, Abhijit, "Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS." Journal of the American Academy of Dermatology. 82, 6. 1328 - 1336. (2020).
https://digitalcommons.wustl.edu/oa_4/1430
Additional Links
Supplemental material is available for this article at publisher site.
